Abstract:Background Aging is significantly associated with the incidence and progression of atrial fibrillation (AF) incidence. This study aimed to evaluate the potential predictive value of leukocyte telomere length (LTL) for progression from paroxysmal AF (PAF) to persistent AF (PsAF) after catheter ablation. Methods and Results A total of 269 patients with AF (154 patients with PAF and 115 patients with PsAF, respectively) were prospectively enrolled, and all patients with PAF at baseline were regularly followed up to determine whether and when they should progress to PsAF after catheter ablation therapy. Baseline relative LTL was measured by quantitative real-time PCR (rt-PCT). There was a significant negative association between LTL and age ( r = −0.23, p < 0.001). Patients with PsAF had significantly shorter LTL than those with PAF. After a mean follow-up of 854.9 ± 18.7 d, progression events occurred in 35 out of the 154 patients with PAF. Those progressed patients with PAF were older (70.9 ± 8.0 vs. 62.3 ± 10.3, p < 0.001) and had shorter LTL (1.2 ± 0.3 vs. 1.5 ± 0.3, p < 0.001) than those who did not. The receiver operating characteristic (ROC) curve analysis showed a significant value of LTL in distinguishing patients with PAF from patients with PsAF, with an area under the ROC curve (AUC) of 0.63 (95% CI 0.56–0.70, p < 0.001), and the optimal cut-off value of LTL was 1.175, with a sensitivity and specificity of 56.03 and 82.04%, respectively. All patients with PAF were divided into two subgroups according to the optimal cut-off point of LTL calculated by the ROC curve analysis: high LTL group (≥1.175) and low LTL group (<1.175). Kaplan-Meier curve analysis showed that PAF patients with shorter LTL had a significantly higher rate of progression after catheter ablation (40.5% vs. 18.8%, log-rank test p < 0.001). Multivariate Cox proportional-hazards model indicated that LTL [hazard ratio (HR): 2.71, 95% CI 1.36–5.42, p = 0.005] was an independent predictor for progression from PAF to PsAF after catheter ablation therapy, but HATCH score was not (HR: 1.02, 95% CI: 0.68–1.52, p = 0.923). Conclusion Leukocyte telomere length was significantly associated with AF types. LTL was independently associated with progression from PAF to PsAF after catheter ablation therapy. Chinese Clinical Trial Registry, Registration Number: ChiCTR1900021341.

Leukocyte Telomere Length is Associated with Disability Progression in Multiple Sclerosis Independent of Chronological Age

Leukocyte telomere length in multiple sclerosis: relationship between disability severity and pregnancy history

Leukocyte Telomere Length Predicts Severe Disability in Relapsing-Remitting Multiple Sclerosis and Correlates with Mitochondrial DNA Copy Number

Telomere length as a biomarker in multiple sclerosis

Accelerated Leukocyte Telomere Erosion in Schizophrenia: Evidence from the Present Study and a Meta-Analysis

Leukocyte telomere length: Effects of schizophrenia, age, and gender

Leukocyte Telomere Length and Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study

Unusual Age-Dependent Behavior of Leukocytes Telomere Length in Friedreich's Ataxia

Long-term disability trajectories in multiple sclerosis: a group-based trajectory analysis of the AusLong cohort

Leukocyte telomere length and attrition in association with disease severity in cystic fibrosis patients

Shorter Telomere Length in Peripheral Blood Leukocytes is Associated with Childhood Autism

Association Between The Length Of Leukocyte Telomeres And Functional Performance Of Older Adults: Observational Study

Chronic and Latent Viral Infections and Leukocyte Telomere Length across the Lifespan of Female and Male Individuals Living with or without HIV

Leukocyte Telomere Length Variation in Different Stages of Schizophrenia.

Confirmed disability progression as a marker of permanent disability in multiple sclerosis

Impact of Clinical and Demographic Factors on Disease Progression

Locus for severity implicates CNS resilience in progression of multiple sclerosis

Epigenome-wide association study of leukocyte telomere length.

Is the telomere length associated with neurocognitive disabilities in HIV-1-infected subjects?

Longer Leukocytes Telomere Length Predicts a Significant Survival Advantage in the Elderly TRELONG Cohort, with Short Physical Performance Battery Score and Years of Education as Main Determinants for Telomere Elongation

Leukocyte Telomere Length Predicts Progression From Paroxysmal to Persistent Atrial Fibrillation in the Long Term After Catheter Ablation